Articles

The TGA has clarified that state and territory governments will continue to regulate fluoridated drinking water in Australia

Medicines Safety Update article

The TGA is urging Australians to return unused prescription pain relief medicines to their local pharmacy

New regulations for stem cell treatments in Australia came into force on 1 July 2019

The 2019 TGA stakeholder survey is open. Have your say before 5 July

We're encouraging all Australians to return their unused opioids to their local pharmacy

International work-sharing initiative approves Niraparib (Zejula®)

The transition period for updating medicine ingredient names ends on 30 April 2020.

Bee aware of the risks of natural medicines and medical devices.

The Therapeutic Goods (Permissible Ingredients) Determination has been updated.

Over the last few years we've updated the Australian names of some medicine ingredients to bring the names into line with the names used in other countries.

Reasons for releasing guidance and how it was developed

On Thursday 30 May 2019, the Therapeutic Goods Administration (TGA) executed four search warrants connected to a business operating in the Sutherland Shire, Sydney

The TGA has seized black salve products after executing a search warrant at a business premises on the Gold Coast

Court action continues against Peptide Clinics Australia for alleged advertising breaches

TGA data analysis

Provided all appropriate rules are followed, many medicines can be imported for personal use under the Personal Importation Scheme.

Medicines Safety Update article

Heading overseas? Read our tips for travelling with medicines before you go

Second candidate in international work-share initiative

Do your research before consenting to live blood analysis, electrodermal testing and other related tests

Tim's story explains the risks of buying SARMs online.

Learn how we manage complaints about therapeutic goods advertising.

Indications proposed by industry during the 2017 public comment period have been published

Australian launch of a new product called Nyxoid nasal spray for opioid overdoses